KOHJIN BIO CO LTD (177A.T)
JPY 1670.0
(3.73%)
JPY 1670.0
(3.73%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.77 Billion JPY | 0.57% |
| 2022 | 4.74 Billion JPY | 20.16% |
| 2021 | 3.94 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 FY | 4.77 Billion JPY | 0.57% |
| 2023 Q4 | 1.22 Billion JPY | 0.0% |
| 2022 FY | 4.74 Billion JPY | 20.16% |
| 2021 FY | 3.94 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -4124.09% |
| GNI Group Ltd. | 26.01 Billion JPY | 81.661% |
| Linical Co., Ltd. | 12.3 Billion JPY | 61.244% |
| Trans Genic Inc. | 13.08 Billion JPY | 63.541% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -621.056% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 7.529% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | -205.699% |
| AnGes, Inc. | 152.98 Million JPY | -3018.015% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -681.832% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 62.634% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | -484.069% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -3420.158% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | -193.384% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -1013.561% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | -150.899% |
| Chiome Bioscience Inc. | 682.46 Million JPY | -598.952% |
| Kidswell Bio Corporation | 2.43 Billion JPY | -96.201% |
| PeptiDream Inc. | 28.71 Billion JPY | 83.387% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -7467.017% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -3842.228% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -6625033.333% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -11859.024% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | -5.754% |
| FunPep Company Limited | 530 Thousand JPY | -899918.113% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -6788.225% |
| Stella Pharma Corporation | 269.49 Million JPY | -1670.039% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -1405.627% |
| Cuorips Inc. | 23.1 Million JPY | -20547.979% |
| K Pharma,Inc. | 1 Billion JPY | -377.01% |
| Takara Bio Inc. | 43.5 Billion JPY | 89.036% |
| ReproCELL Incorporated | 2.42 Billion JPY | -96.558% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | -178.088% |
| StemCell Institute Inc. | 2.48 Billion JPY | -92.25% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | -89.727% |
| CellSeed Inc. | 190.13 Million JPY | -2408.807% |